In this translational study, the authors identify a novel pathway involving formylpeptide receptor (FPR)1-NOD-like receptor (NLR)C4 inflammasome activation to drive proinflammatory responses in barrier-disrupted skin.

doi.org/10.1093/bjd/lj…

What do Hyperhidrosis Quality of Life Index (HidroQoL©) scores mean? Transferring science into practice by establishing a score banding system

doi.org/10.1093/bjd/lj…

Severity, impact on quality of life and mental health burden of pruritus in prurigo nodularis: a cross-sectional study of a diverse patient cohort

doi.org/10.1093/bjd/lj…

In this cohort study, the authors examined the relationship between pediatric atopic dermatitis (AD) and intellectual ability between 1.5 and 15.5 years of age, finding no meaningful associations between AD activity or severity and general cognition.

doi.org/10.1093/bjd/lj…

Read the April 2024 issue of the BJD at the link below!

academic.oup.com/bjd/issue/190/4

Guidelines for cold urticaria management established by the Centre of Evidence of Dermatology and the Urticaria Group of the French Society of Dermatology

doi.org/10.1093/bjd/lj…

In this analysis of the Korean National Health Interview Service, psoriasis was found to be most associated with cumulative metabolic syndrome burden in the oldest age group, suggesting the importance of managing metabolic syndrome in mid-life and beyond.

doi.org/10.1093/bjd/lj…

We wrote this article in BJD providing a commentary on recent work by Dainty et al. and highlighting the importance of supporting people experiencing flares in skin conditions Prof Andrew R Thompson 💙

academic.oup.com/bjd/advance-ar…

Excited to announce my 1st publication in the British Journal of Dermatology BJD Oxford Academic w/ David Garate under John Barbieri, MD, MBA

We investigated tetracycline use in acne patients and idiopathic intracranial hypertension risk.

Read Here: academic.oup.com/bjd/advance-ar…

Multiple long-term conditions in people with psoriasis: a latent class and bidirectional Mendelian randomization analysis

doi.org/10.1093/bjd/lj…

In this translational study, the authors characterize the identity, origin, and functions of mononuclear phagocytes in human cutaneous graft-versus-host disease and examine how they contribute to distinct manifestations of illness.

doi.org/10.1093/bjd/lj…

With the advent of RNA-based medicine, PVT1 may be a promising molecular target for the management of inoperable or metastatic cutaneous squamous cell carcinoma (cSCC). Increased expression of PVT1 may serve as a biomarker for cSCCs.

doi.org/10.1093/bjd/lj…

In a new BJD study, researchers including @YaleDerm’s Jeffrey Cohen, MD, find people with atopic #dermatitis ( #eczema ) are at significantly higher risk for #eatingdisorders like #anorexia , #bulimia and #bingeeating disorder. brnw.ch/21wI16l

.BJD invites submissions under a broad scope of topics relevant to clinical and experimental research.

Publish with BJD to broaden the reach and impact of your research: oxford.ly/43qVvUr
#AAD24

In this international eDelphi and consensus study, the authors identify three core domains achieving criteria for inclusion in #PyodermaGangrenosum clinical trials: pain, clinical signs, and quality of life. #DermTwitter

doi.org/10.1093/bjd/lj…

Epidemiology of alopecia areata and population-wide comorbidities in Germany: analysis of longitudinal claims data

doi.org/10.1093/bjd/lj…

We hope everyone had an amazing time at AAD! Here’s our Editor-in-Chief John Ingram with a few words on his experience at AAD, and the importance of international conferences in sharing the latest breakthrough research in dermatology.

Are you attending the #AAD24 annual conference? Share your passion for dermatological research by publishing your work in BJD, the home for the latest research in dermatology.

Submit your manuscript today: oxford.ly/48KB1XU

In this study of the BIOBADADERM registry, the authors found that combination of a biologic with methotrexate for treatment of moderate-to-severe psoriasis was not associated with significant increases in risk of adverse events in any treatment group.

doi.org/10.1093/bjd/lj…

Beremagene geperpavec (B-VEC) gene therapy for the treatment of cutaneous wounds in patients with dystrophic epidermolysis bullosa: a critically appraised research paper

doi.org/10.1093/bjd/lj…